中华风湿病学杂志
中華風濕病學雜誌
중화풍습병학잡지
CHINESE JOURNAL OF RHEUMATOLOGY
2009年
6期
400-402
,共3页
王胜%方伟%张榜硕%牟庆云%钟晖%陈永平
王勝%方偉%張榜碩%牟慶雲%鐘暉%陳永平
왕성%방위%장방석%모경운%종휘%진영평
关节炎,实验性%自身抗体%细胞因子类%丹皮酚
關節炎,實驗性%自身抗體%細胞因子類%丹皮酚
관절염,실험성%자신항체%세포인자류%단피분
Arthritis,experimental%Autoantibodies%Cytokines%Paeonol
目的 观察中药丹皮酚对胶原诱导性关节炎(CIA)的治疗作用,并初步探讨其作用机制.方法 以胶原诱导法构建关节炎小鼠模型,将成功造模的小鼠随机分为磷酸盐缓冲液(PBS)阴性对照组、甲氨蝶呤(MTX)阳性对照组和丹皮酚组,分别给予相应处理,观察丹皮酚对CIA的临床评分、血清细胞因子、Th17及自身抗体滴度的影响.结果 丹皮酚能明显降低关节炎分值(2.36±044,P<0.01),抑制Th1型炎性细胞因子白细胞介素(IL)-12(463±56,P<0.05)、肿瘤坏死因子(TNF)-α(248±66,P<0.01)、干扰素(IFN)-γ(325±40,P<0.05)、IL-6(282±43,P<0.01)等的产生,促进Th2型细胞因子IL-4(1411±683,P<0.01)和IL-10(325±35,P<0.05)分泌,下调脾脏细胞中Th17丰度(1.73%,P<0.05),降低血清抗Ⅱ型胶原自身抗体含量(A值=0.064,P<0.01).结论 丹皮酚对CIA具有良好的治疗效果,为研发治疗人类类风湿关节炎药物提供一条新思路.
目的 觀察中藥丹皮酚對膠原誘導性關節炎(CIA)的治療作用,併初步探討其作用機製.方法 以膠原誘導法構建關節炎小鼠模型,將成功造模的小鼠隨機分為燐痠鹽緩遲液(PBS)陰性對照組、甲氨蝶呤(MTX)暘性對照組和丹皮酚組,分彆給予相應處理,觀察丹皮酚對CIA的臨床評分、血清細胞因子、Th17及自身抗體滴度的影響.結果 丹皮酚能明顯降低關節炎分值(2.36±044,P<0.01),抑製Th1型炎性細胞因子白細胞介素(IL)-12(463±56,P<0.05)、腫瘤壞死因子(TNF)-α(248±66,P<0.01)、榦擾素(IFN)-γ(325±40,P<0.05)、IL-6(282±43,P<0.01)等的產生,促進Th2型細胞因子IL-4(1411±683,P<0.01)和IL-10(325±35,P<0.05)分泌,下調脾髒細胞中Th17豐度(1.73%,P<0.05),降低血清抗Ⅱ型膠原自身抗體含量(A值=0.064,P<0.01).結論 丹皮酚對CIA具有良好的治療效果,為研髮治療人類類風濕關節炎藥物提供一條新思路.
목적 관찰중약단피분대효원유도성관절염(CIA)적치료작용,병초보탐토기작용궤제.방법 이효원유도법구건관절염소서모형,장성공조모적소서수궤분위린산염완충액(PBS)음성대조조、갑안접령(MTX)양성대조조화단피분조,분별급여상응처리,관찰단피분대CIA적림상평분、혈청세포인자、Th17급자신항체적도적영향.결과 단피분능명현강저관절염분치(2.36±044,P<0.01),억제Th1형염성세포인자백세포개소(IL)-12(463±56,P<0.05)、종류배사인자(TNF)-α(248±66,P<0.01)、간우소(IFN)-γ(325±40,P<0.05)、IL-6(282±43,P<0.01)등적산생,촉진Th2형세포인자IL-4(1411±683,P<0.01)화IL-10(325±35,P<0.05)분비,하조비장세포중Th17봉도(1.73%,P<0.05),강저혈청항Ⅱ형효원자신항체함량(A치=0.064,P<0.01).결론 단피분대CIA구유량호적치료효과,위연발치료인류류풍습관절염약물제공일조신사로.
Objective To observe the effects of paeonol on collagen induced arthritis (CIA) and investigate its mechanisms. Methods The tentative arthritis mice model was created by injecting type Ⅱ collagen. The severity degree of RA was scored according to the rating criteria after treatment with paeonol. ELISA method was employed to detect the levels of IL-12, TNF-2, IFN-γ and anti-type Ⅱ collagen autoantibody. The efficacy of paeonol was compared with that of MTX (the positive control) and PBS was used as the negative control. Results We found that paeonol could alleviate severe RA, inhibit the expression of inflammatory cytokines such as IL-12, TNF-2, IFN-γ and reduce the level of anti-type Ⅱ collagen autoantibody in serum, which was similar with MTX. Conclusion The results show that paeonol has a reliable therapeutic effect for RA. This study has provided a good clue for the future research and development of medications for the treatment of RA.